Right ventricular outflow tract obstruction risk factors

Revision as of 16:29, 24 June 2011 by C Michael Gibson (talk | contribs) (New page: {{CMG}} A recent review by the Mayo clinic does not support the role of SSRIs in the development of congenital heart disease. <ref name="pmid19121250">{{cite journal| author=Wichman CL, ...)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

A recent review by the Mayo clinic does not support the role of SSRIs in the development of congenital heart disease. [1]

  1. ↑ Wichman CL, Moore KM, Lang TR, St Sauver JL, Heise RH, Watson WJ (2009). "Congenital heart disease associated with selective serotonin reuptake inhibitor use during pregnancy". Mayo Clin Proc. 84 (1): 23–7. PMC 2664566. PMID 19121250.
Retrieved from "https://www.wikidoc.org/index.php?title=Right_ventricular_outflow_tract_obstruction_risk_factors&oldid=574886"